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ABSTRACT 
CORRELATION OF VISUALIZED GLUCOCORTICOID RECEPTOR AND 
APOPTOSIS IN INDIVIDUAL CLONES OF NB2 CELLS 
Devang Patel 
A thesis submitted in partial fu lfillment of the requirements for the degree of Master in 
Sc ience at Virginia Commonwealth University. 
V irginia Commonwealth University, 1 999 
Director: Raphael J. Witorsch, Ph.D. ,  Professor, Department of Physiology 
The Nb2 lymphoma cell l ine is susceptible to glucocorticoid (GC)-induced apoptosis in 
the absence of mitogen and this effect is inhibited by the mitogen prolactin (PRL). This 
process is believed to be mediated by the glucocorticoid receptor (GR) and various 
downstream signals. The purpose of this study was to use the l imiting dilution method to 
isolate subsets of Nb2 clones which expressed either h ighly enriched amounts of GR or 
an absence of GR and to relate the amount of GR to the magnitude of GC induced 
cytolysis. The presence of GR in these clones was determined by immunocytochemistry 
(ICC) using an affinity purified polyclonal rabbit antibody directed towards the GR. The 
presence of GR was then correlated to cytolysis in these cel ls produced by incubation 
with dexamethasone (Dex), a synthetic GC, in the presence and absence of PRL. 
x 
Cytolysis was measured by two different methods, Trypan Blue exclusion counts, to 
determine the percentage of dead and the TUNEL (TdT-dependent dUTP-biotin Nick End 
Label ing) assay used to label apoptotic cells. The l imiting dilution produced 28 clones 
with varying amounts of GR and all were responsive to Dex and this response was 
inhibited by PRL. A significant correlation (r2=0.4 1 9  and p<O.OOO I )  was observed 
between the percentage of cells stained for GR and the % dead cel ls after Dex treatment. 
Comparison of mean values for percent dead and percent TUNEL labeled for DMSO, 
Dex±PRL, and PRL alone for clones and wild types (assayed along with clones) revealed 
that these two endpoints of apoptosis were in close agreement with one another. The 
mean values of the percentage of cel ls undergoing apoptosis agreed closely with the 
percentage of cells labeled for GR. Furthermore the mean values for all treatments of the 
clones were very similar to those obtained for the wild type cells.  It is concluded that the 
cytolytic response to dexamethasone is representative of the apoptotic response and that 
the GR observed by ICC is a quantitative predictor of the apoptotic response to Gc. 
Chapter 1 
INTRODUCTION 
Apoptosis,  also known as programmed cell death, is a vital process in the survival , 
renewal ,  and maintenance of many tissues (Wyll ie,  1 980; Gavriel i  et a! . ,  1 992).  This 
selective deletion of cells is responsible for many changes in the embryonic development 
of organisms such as the deletion of interdigital webbing and the proper formation of the 
retina (Hammar et a! . ,  1 97 1 ;  Penfold et a! . ,  1 986; Gerschenson et a! . ,  1 992). Apoptosis 
has also been implicated in cytotoxic immunological reactions (Hasbold et a! . ,  1 990; 
Strasser et a! . ,  1 99 1 ;  Gorczyca et a! . 1 993) and as the process of death for differentiated 
cells at the end of their l i fe span (Appleby et a! . ,  1 977;  Benedetti et a! . ,  1 988 ;  Gorczyca et 
a! . 1 993) .  The involvement of apoptosis in these processes as well as other cel lu lar 
deletion processes has increased interest in how tumor cells may respond to antitumor 
agents (Wi l l iams, 1 99 1 ) . 
Apoptosis is a distinct, well-coordinated process by which cells commit suicide due to 
specific intracellular signals (Gerschenson, 1 992). The morphological changes that cel l s  
undergo during programmed ce l l  death led Kerr and Searle to  name this phenomenon 
"apoptosis" from the Greek "falling off' (Kerr et aI . ,  1 972; Gerschenson et aI . ,  1 992) .  
This specific pattern of morphological and biochemical changes differentiates apoptosis 
from necrosis, the process of cell death induced by injury or trauma (Gerschenson et aI . ,  
1 992) .  
Necrosis is the manner of cel l death most often associated with disease, toxins and 
hypoxemia. Necrotic cells are identified by swell ing and rupturing due to a loss of ion 
balance and osmoregulation in response to the trauma or injury just described. The 
ruptured contents of the necrotic cell are released into the extracellu lar matrix where 
intracellular proteases and toxic enzymes can cause necrotic death of neighboring cel ls 
and inflammation of the effected tissue ( Ameisen, 1 995).  Necrotic cel ls  also undergo a 
random breakdown of DNA in a single and double stranded manner. This random 
fragmentation of the DNA resu lts in a smear when the DNA is subjected to gel 
electrophoresis (Gerschenson et aI . ,  1 992). 
2 
In contrast to necrotic cells, apoptotic cel ls shrink due to an active loss of intracel lular 
fluid which is accompanied by blebbing of the cell surface due to fusion of the swollen 
endoplasmic reticulum with the cytoplasmic membrane. Concurrent with these 
cytoplasmic changes the nucleus compacts and begins to form discrete fragments. These 
cel l s  then break into apoptotic bodies which are membrane bound fragments of the cel l 
with cytoplasmic organelles and some nuclear material (Wyll ie,  1 980; Gerschenson et aI . ,  
1 992). These apoptotic bodies are often phagocytized by adjacent cells or  by 
3 
macrophages which means complete removal of the cell and its contents without 
exposing surrounding cells to any toxicity in the apoptotic cell. An important 
characteristic of apoptosis is the active nature of the process requiring gene regulation and 
RNA synthesis .  Thus apoptosis involves many intracellular signals which participate in  
concert to  establish an organized process of cel l self-destruction (Wil l iams, 1 995).  
Biochemically, the most characteristic property of apoptosis is the double strand c leavage 
of DNA in the l inker regions between DNA. The fragmentation of the DNA in apoptosis 
results in irreparable damage that commits the cell to death (Wyl l ie, 1 980; Arends et aI . ,  
1 990; Gerschenson e t  aI . ,  1 992). During a n  apoptotic event, endogenous endonucleases 
are activated to c leave the DNA in the manner described (Wyl l ie, 1 980). The 
doublestranded DNA is wrapped around a nucleosomal core of h istone proteins twice 
( 1 80 base pairs) with linker DNA connecting adj acent nucleosomes (McGhee et aI . ,  
1 980). The Ca2+ and Mg2+ dependent endonucleases (Cohen et aI., 1 984) cleave a t  these 
internucleosomal regions and produce DNA fragments of approximately 1 80 base pairs or 
multiples of that number (Gerschenson et aI., 1 992). This fragmentation results in the 
characteristic DNA ladder pattern when the DNA from apoptotic cells is subjected to 
agarose gel e lectrophoresis (Kerr et aI . ,  1 972). 
4 
Apoptosis is believed to occur by activating specific cysteine proteases collectively 
known as caspases. Caspases exist as pro-enzymes which must be activated. The 
apoptotic triggers (oxidants, cerami de, caspases, etc . )  are bel ieved to cause a compromise 
of the mitochondrial membrane. This may occur either by matrix swelling which causes 
the outer membrane to rupture or by the opening of channels in the mitochondria. The 
mitochondria then releases cytochrome c which in tum binds to and activates a cytosolic 
protein known as apoptotic protease-activating factor I (Apaf- I ) . Apaf-I activates 
caspase-9 which activates a cascade of other caspases (Green, et aI . ,  1 998).  The activated 
caspases commit the cell to death by various actions. They wi l l  in i t iate degradation of 
nuclear lamins which are intermediate filament proteins which polymerize to form the 
rigid understructure of the nuclear membrane. This degradation resu lts in nuclear 
membrane destruction/condensation. Caspases also activate depolymerization of 
cytosolic proteins such as gelsolin and actin leading to cytoplasmic blebbing. Other 
caspases inactivate inhibitors of proteins that promote apoptosis such as the cleavage of 
fAD. Caspase-activated deoxyribonuclease (CAD) is a nuclease responsible for DNA 
laddering and is normally  bound to i t s  inhibitor fAD, but th is  inhibitor i s  c leaved by 
caspases and the CAD translocates to function in the nucleus. Caspases are in  a sense 
the machinery which carries out the destruction of the cel l  targeted for apoptosis 
(Thornberry et aI . ,  1 998).  
5 
Glucocorticoids have long been used c l inical ly to suppress inflammation and the immune 
response although the mechanism of this was poorly understood (Auphan et a ! . ,  1 995). 
Lymphocytes which are treated with glucocorticoids wi l l  show the characteristic 
apoptotic death described above, and this is often shown by using the synthetic 
glucocorticoid, dexamethasone (Wyll ie,  1 980). The glucocorticoid (GC) works by 
binding to the g lucocorticoid receptor (GR) which then translocates to the nucleus where 
it acts as a nuclear transcription factor. The GR normal ly localizes in the cell cytoplasm 
wait ing to be activated by GC as a l igand regulated transcription factor (Flomerfelt  et a! . ,  
1 994).  The GR has a non-conserved amino terminus, but the highly conserved DNA 
binding domain contains two cysteine zinc fingers which are the DNA response element 
(Vedeckis, 1 992). Exactly which genes are turned on and off by the GR is not completely 
known. 
GCs have been shown to interfere with the function of the nuclear factor kappa B (NFKB) 
in lymphocytes and this is thought to be the pathway by which GCs mediate 
i mmunosupression (Schein man et a! . ,  1 995) .  NFKB is bel ieved to protect against 
apoptosis via its activity as a protein transcription factor and it is activated by cytokines, 
such as Tumor Necrosis Factor (TNF), to turn on genes involved in the immune response 
(Barinaga, 1 996). NFKB is a heterodimer consisting of a 50-kD protein  (p50) and a 65-
kD protein (p65) .  In an unstimulated cel l ,  NFKB is bound and repressed in the cytoplasm 
6 
by the 37-kD protein I1d3a. I1d3a binds to NF1d3 and prevents its translocation to the 
nucleus where i t  may regulate gene transcription (Israel ,  1 995) .  When factors such as 
TNF stimulate a cell, the I1d3a is quickly degraded due to a phosphorylyation at the 
conserved amino acid residues Ser32 and Ser36. This releases NF1d3 and al lows for its 
translocation to the nucleus ( Brown et aI . ,  1 995) .  Thus, the activation and translocation 
of NF1d3 is important in protecting the cell from apoptosis. Glucocorticoid-induced 
apoptosis has been shown to occur by disrupting this process. The activated GR 
translocates to the nucleus where i t  binds the appropriate DNA response element to 
induce transcription of I1d3a (Scheinman et aI ., 1 995) .  This upregulation of 11d3a 
synthesis wi l l  lead to more of the protein being available to bind NF1d3 and prevent its 
activation in  the nucleus (Auphan et aI . ,  1 995) .  This lymphocyte i mmunosuppression 
effect of GR mediated by I1d3a (Auphan et al . ,  1995) in effect induces apoptosis  in the 
cell by negating the protective properties of NF1d3 (Beg et aI . ,  1 995) .  
The Nb2 lymphoma cel l  l ine i s  a useful model for studying the regulation of signals 
involved in GC-induced apoptosis .  This particular cell l ine has been studied and 
characterized extensively by previous work in our laboratory. The cell  l ine was i solated 
from an estrogen treated male Noble rat (Noble et aI ., 1 985). Further studies showed that 
this cell l ine is of thymic origin at an intermediate stage of differentiation as determined 
by the presence of surface antigens expressed (Fleming et aI ., 1 982).  Nb2 cel ls  require 
7 
prolactin (PRL) or other lactogenic hormones for prol iferation (Noble et aI . ,  1 985) .  The 
amount of human, ovine, bovine, or rat PRL required for prol iferation ranges from 
1 0pg/ml to I ng/ml making the Nb2 cells highly sensit ive to lactogenic hormones. This 
specificity and sensitivity allows for the use of the Nb2 cell l i ne as an in  vitro bioassay 
system for measuring serum lactogens (Tanaka et aI . ,  1 980). 
Knowing that GCs promote cytolysis in lymphocytes (Compton et aI . ,  1 986), specific 
properties of this relationship were examined in this laboratory using the Nb2 cel l  l i ne .  
Us ing  the  synthetic GC,  dexamethasone (Dex), Fletcher-Chiappini et al . ( 1 993) showed 
that GCs induce apoptosis  in the Nb2 cell in a receptor-mediated and dose dependent 
manner. The same work also revealed that Dex inh ibits the mitogenic properties of PRL 
on the Nb2 in a dose-dependent manner and that PRL inhibits the Dex apoptotic effect, 
also in a dose-dependent manner. LaVoie further examined the anti-apoptotic action of 
PRL by using agonists and antagonists of signals implicated in prolactin induction of 
mitogenesis in Nb2 cells .  The inhibition of tyrosine phosphatase in  the presence of basal 
tyrosine kinase activity mimicked the anti-apoptotic action of PRL. Those studies 
suggested that tyrosine phosphorylation participation is involved in the anti-apoptotic 
effect of PRL (LaVoie and Witorsch, \995). 
Studies from other laboratories have also implicated the importance of tyrosine 
phosphorylation in  PRL action. The action of PRL on lymphocytes is mediated by the 
8 
PRL receptor (PRL-R) and two of its principle signaling pathways, the JAKJST AT and 
MAPK protein kinase cascades. Both of these pathways involve multiple tyrosine 
phosphorylations for signal activation (Yu-Lee, 1 997) .  The PRL-R is a member of the 
cytokine receptor family and does not exhibit intrinsic kinase or catalytic domains on its 
i ntracel lu lar domains ( Kel ly, 1 99 1 ) . The PRL-R signaling occurs by signal transduction 
mediated by receptor-associated protein tyrosine kinases (PTK) such as Janus Associated 
Kinase 2 (JAK2) .  PRL binding to the receptor results in PRL-R dimerization (Elberg, 
1 990) which activates JAK2. JAK2 then phosophorylates two tyrosine residues on the 
PRL-R intracytoplasmic domain (Campbel l ,  1 994), Y382 and Y309. These two tyrosine 
residues are particularly important for the prol iferation of Nb2 cel l s  (Yu-Lee, 1 997). 
These phosphorylated tyrosines are believed to serve as docking sites for a group of latent 
cytoplasmic transcription factors called signal transducers and activators of transcription 
(ST A T) (Stahl ,  1 995) .  STAT I ,  ST AT5, and ST AT3 have been shown to be PRL­
inducible.  J AK2 then phosphorylates the ST ATs activating them to form homodimers 
with other STATs via SH2 domain mediated by phosphorylated tyrosines. This activated 
STAT complex wi l l  translocate to the nucleus and bind to its corresponding DNA 
response element to regulate gene transcription (Yu-Lee, 1 997). 
In addition to the JAKJST AT pathway described above, the activation of other protein 
kinase cascades has been implicated in the mitogenic effect of PRL on the Nb2 cell .  The 
activation of MAPK is required for the protein synthesis which occurs during 
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mitogenesis,  but MAPK activation alone wi l l  not lead to PRL induced mitogenesis of the 
Nb2 cell (Carey et aI . ,  1 995; Carey et aI . ,  1 998).  The MAPK pathway is usual ly  
associated with the growth factor kinase receptor (e.g. GRB2, SOS, RAS, Raf- I ,  MEK, 
MAPK) and also involves tyrosine phosphorylation at several sites, namely JAK 
autophosphorylation, PRL-R phosphorylation and tyrosine phosphorylation of MAPK 
(Camaril lo  et aI . ,  1 997) .  
Recent work in our laboratory has focused on a more morphological approach to  studying 
the signals involved in hormonal control of apoptosis in Nb2 cel ls .  Detection and 
characterization of apoptotic cel ls usual ly involves biochemical and molecular biological 
methods, such as measurements of DNA fragmentation by the diphenylamine assay and 
agarose gel e lectrophoresis ,  and quantitation of signals by Western blot analysis. All of 
these involve disrupted cel l  populations which prevents the detection of apoptotic activity 
and signaling in  individual cells (Gavriel i  et aI . ,  1 992). 
In contrast to disrupted cell techniques, Guanzon uti l ized a morphological and 
immunocytochemical approach to examine the signals involved in Dex-induced 
apoptosis. This provided a v iew of the GC-induced apoptosis at the individual cel lular 
level rather than as a population of disrupted cel ls (Guanzon, MS thesis,  1 998) .  In 1 992 
Gavriel i  designed the TUNEL assay as an immunological method of detecting 
cell -specific apoptosis .  The assay capitalizes on the DNA fragmentation evident in 
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apoptotic cells by label ing these broken DNA strands with biotinylated dUTP using the 
enzyme term inal deoxynucleotidyl transferase (TdT). The signal is ampl ified by avidin­
peroxidase and visual ized with the insoluble chromaphore diaminobenzidene (DAB) .  
With th is  methodology, individual cel ls in a population can be  determined as having 
undergone apoptosis  and the cellular morphology of those particular cel ls can also be 
visual ized (Gavriel i  et aI . ,  1992). Tornusciolo took this concept one step further by 
proposing that immunocytochemistry (ICC) could be performed on these TUNEL labeled 
cel ls to determine the immunophenotype of apoptotic cel ls (Tornusciolo et a!. ,  1 995) .  
Guanzon used immunocytochemistry to examine several intracel lular signals (GR, NFKB , 
IKBa, and STAT5b) in synchronized (GofG1) Nb2 cel ls induced to undergo apoptosis  by 
GC exposure. ICC analysis of the Nb2 cells revealed that approximately 40% of the cel ls 
displayed staining for GR, NFKB, IKBa as well as STAT5b and that number did not 
change upon exposure to Dex. Furthermore, no translocation of GR or NFKB from the 
cytoplasm to nucleus could be detected. TUNEL labeling of synchronized Nb2 cells was 
detectable 6-8 hours after addition of Dex to the cel l s  which correl ated with all death as 
measured by Trypan B lue exclusion. Previous studies using gel electrophoresis and the 
diphenylamine assay detected apoptotic activity in as l i ttle as four hours (Guanzon, M .S. 
thesis,  1 998) .  
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Guanzon's observations raised important questions about the intracel lular signals 
involved in GC induced Nb2 cel l apoptosis. First, was it merely coincidence that the 
same percentage of cells were immunostained for all the signals and that this percentage 
corresponded to how many cel ls  underwent apoptosis by GC induction, or was this a 
single subset of cells containing all the signals examined? Secondly, did the relatively 
low proportion of cells containing GR limit the abi l ity to detect changes resulting from 
GC induced apoptosis? Thus, the main objective of this study was to overcome the 
l imitations mentioned above by trying to clone a GR enriched cell line using the l imiting 
di lution method. 
We hoped to use the l imiting di lution to generate clones of the Nb2 cell in which 1 00% of 
the cel l s  were GR positive or at least enriched in  GR. The expectation was that vastly 
different clones would be generated, either very h igh or very low presence of GR. With 
this expectation, we intended to quantitate GR by ICC and then relate these levels to GC 
induced effects of apoptosis by Trypan Blue exclusion and the TUNEL assay. Other 
studies in the laboratory examined the other signals involved in apoptosis. 
Chapter 2 
MATERIALS AND METHODS 
2. 1 Maintenance of Nb2 Lymphoma Cells 
The cel l  l ine used for all experiments was the wild-type Nb2 lymphoma cell l ine 
(Nb2-U 1 7) provided by Dr. Peter Gout of the Cancer Control Agency of British 
Columbia. The cel ls were resurrected from frozen aliquots stored at -70°C and were then 
maintained in Fischer's Maintenance Medium (FMM). The FMM consists of Fischer's 
Medium (FM) supplemented with 1 0% horse serum (HS), 1 0% fetal bovine serum (FBS ), 
0. 1 rnM �-mercaptoethanol ,  50U/ml penic i l l in ,  50llg/ml streptomycin, and 0.075% 
sodium bicarbonate (Tanaka et aI . ,  1 980). Cell cultures were seeded between 0.5 x 1 05 
and 1 .0 x 1 05 cells/ml and incubated in a water saturated atmosphere with 5% CO2 and 
95% room air at 37°C. These cultures were subcultured in fresh FMM ( 1 :9 or I :  1 9) every 
2nd or 3rd day to maintain a maximal cell  concentration of about 1 .0 x 1 06 cells/m l .  The 
concentration and viab i l ity of cells was determined using the Trypan Blue exclusion test 
in which cell s  were counted with a hemocytometer. Trypan Blue, purchased from Gibco 
BRL, was added to the cel ls (0. 1 ml cel l s  plus 0.9ml Trypan Blue) and three individual 
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aliquots from the mixture were counted for viabi l ity and concentration using a 
hemacytometer (triplicate counts). Triplicate counts were performed to attain accurate 
estimates of cell  number and viabil ity in a t ime-effective manner as determined by 
previous studies in this laboratory (Fletcher-Chiappini ,  1 993) .  
2 .2 Limit ing Dilution 
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The l imiting di lution technique i s  used to isolate subsets of a population of cel ls that give 
a specific response (Mil ler, 1 982).  In this study, the objective was to obtain Nb2 clones 
which exhibited varying proportions of GR. In particular we were interested in obtaining 
c lones that were homogenous in which 1 00% of the cel l s  were GR positive whi le others 
would be 1 00% GR negative. The source of the cells used for the l imiting di lution assay 
were log phase Nb2 wild type cel l s  at a concentration of approximately 1 .0 X 1 06cel ls/mi 
exhibiting a viabil ity of 90% or greater. Four separate aliquots of these source cel ls  were 
counted by Trypan Blue in triplicate (as described above) to ensure an accurate count for 
cel l  concentration and viabi l i ty. An al iquot of the cel l  culture was adjusted to a 
concentration of 1 .0 X 1 06cells/mi in FMM and then subjected to a serial di lution to reach 
a final concentration of 0.5 cel l s/ml .  The 0.5 cel l s/ml di lution was then dispensed into a 
24 wel l  plate at a volume of I ml per wel l .  At this di lution of cells,  one cel l s  is l i kely to 
be plated in every other well which minimizes the possibi l ity of heterogeneity. The 24 
wel l  p lates were then placed in a 5% CO2 incubator at 37°C for 1 0  days. On the tenth 
day, the contents of each well were transferred into 4ml of fresh FMM in six well plates 
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to al low further growth of the clone in fresh medium. After an additional 4-7 days when 
cel l s  were visible in the wells, the concentration of the cel ls in  the well was determined 
by a single count with Trypan Blue. If the concentration of clones was greater than 0.5 x 
1 06cel l s/ml , the contents of the well were transferred to a 50ml flask containing 5ml of 
fresh FMM for a total volume of 1 0mi. When the concentration of the cel l s  in these 
flasks reached 0.75- 1 .0 x 1 06cells/ml (2-4 days), the clones were processed for fixation 
and for exposure to Dex with and without PRL (cytolytic assay). 
2.3 Fixation of Cells for GR Staining and TUNEL Assay 
Once the c lones were determined to be of sufficient concentration for the cytolytic assay, 
samples of the clone cells were fixed for immunocytochemistry for visualization of the 
glucocorticoid receptor and TUNEL assay. For the fixation, a 750111 al iquot of the pre­
counted cel ls  was harvested and added to an equal volume of 7 .4% Formaldehyde (Fisher 
Brand) in 0.0 I M PBS in  an Eppendorf centrifuge tube. The mixture was al lowed to 
incubate at room temperature for 1 0  minutes and was then centrifuged at 1 000 rpm for 5 
minutes. The supernatant was then removed and discarded and a volume of 0.0 I M PBS 
was added to the pellet so that the suspension would have a concentration of 
approximately 3 .0 x 1 06 cells/m!. Ten micro l i ters of the fixed cel l s  were then spotted 
onto Fischer Brand Super Frost Plus microscope s l ides on which circles of 5mm diameter 
had been etched. These spotted cel ls were allowed to dry onto the sl ides for at least 24 
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hours before any immunocytochemistry was conducted on these samples. This method of 
fixation was designated as the "quick fix" method and differed from the method 
previously used in this laboratory (Guanzon, M.S .  thesis, 1 998).  The former method of 
fixation involved pel leting ( 1 000 rpm) of cells and removal of supernatant before the 
addition of 3 .7% formaldehyde to fix the cel ls .  
2.4 Cytolytic Assay 
The cytolytic assay was used to determine the cytolytic response to dexamethasone and 
the protective effect of PRL on the wildtype Nb2 cel ls and each of the Nb2 clones 
generated by the l imiting dilution. Fletcher-Chiappini et al . ( 1 993) and LaVoie ( 1 994) 
had previously established protocols for the assays used in this experiment which we 
employed with some minor modifications. For the cytolytic assay, cells were harvested 
from the c lone samples at a concentration of 0.5- 1 .0 x 1 06 cel l s/ml in FMM with a 
viabil i ty of 90% or higher. During each cytolytic assay, a sample of wi ld type (WT) cel ls 
was treated in the same manner. After centrifugation for 5 minutes at 1 000 rpm at 8-
1 0°C, the  FMM was aspirated and the cel ls  were resuspended in FM as  a washing step. 
The cel ls were re-centrifuged as before and the FM was aspirated. This pel let was 
resuspended in a chemical ly  defined serum free medium designated as synthetic medium 
(SYN). SYN consists of FM containing 0. 1 mM b-mercaptoethanol ,  50U/ml penici l l in, 
50�g/ml streptomycin,  1 5mM Hepes, 0. 1 5% bovine serum albumin (BSA), 4�g/ml 
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l inoleic acid, I mM pyruvate, 1 2/lg/ml transferrin, 1 .5ng/ml selenium, I X v itamins, 0.33X 
amino acids, 1 00/lM spermidine and 0.5mM CaCb at a pH of 7.4 (Walker, 1 987) .  
The concentration and viabi l i ty of these cel ls  in SYN was then determined us ing Trypan 
B lue exclusion. Clones and WT controls exhibiting less than 85% viabi l i ty at this point 
were discarded from further study. For each sample, the cell concentration was adjusted 
by adding SYN so that the final plated volume of I ml in SYN had a cel l  concentration of 
0.5 x 1 06 cells/m!. The cel ls  were plated in 24 well plates with the fol lowing 4-wel l  
design for each sample: 
I :  0 .25% Dimethyl Sulfoxide (DMSO), the vehicul ar control and di luent for Dex 
2: 1 00nM Dex 
3: 1 00nM Dex + I ng/ml oPRL 
4: I ng/ml oPRL 
Dexamethasone ( 1 ,4 pregnadiene-9fluor- 1 6a-methyl- I I �, 1 7a,2 1 -triol-3 ,20-dione) was 
acquired from Sigma Chemical Co. (St. Louis, MO) and the ovine prolactin (oPRL s- 1 5 ) 
was donated by the National Hormone and Pituitary Program. The ovine prolactin was 
di luted in SYN from a frozen stock of 1 0ng/ml oPRL in O.O I N  NaOH. The cel l s  were 
then incubated for 24 hours at 37°C in a 5% CO2 incubator. After 24 hours the 
concentration and viabil i ty of the cel ls was again determined in tripl icate by Trypan Blue 
exclusion. Samples from the wel ls were then taken and subjected to the quick fix 
protocol for the TUNEL assay. 
2.5 TUNEL (Tdt-dependent dUTP-biotin Nick End Labeling) Assay 
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The TUNEL assay used was purchased as a kit from Trevigen Inc . ,  Maryland. The 
protocol provided by Trevigen was followed with minor modifications (Guanzon, MS 
thesis,  1 998) .  The TUNEL assay uses the DNA ends of fragmented apoptotic DNA as  a 
substrate for the enzyme Terminal deoxynucleotidyl Transferase (TdT). TdT catalyzes 
the formation of complexes of covalently bound biotinylated nucleotides at the DNA ends 
generated by apoptosis ,  and these biotinylated nucleotides can be visual ized using 
streptavidin-horseradish peroxidase conjugate. The streptavidin conjugate reacts with 
diaminobenzidine (DAB) to form a visible insoluble colored substrate at the site of 
apoptotic fragmentation (Trevigen, Inc . ,  1 996). The spotted sl ides were immersed in 
0.0 I M PBS for 10 minutes at room temperature to hydrate the cells fixed on the sl ides. 
Cel ls  were then treated with Cytopore detergent at room temperature for 20 minutes to 
permeabi l ize the cells .  After washing the cells in O.OI M  PBS, the exogenous peroxidase 
activity was quenched by immersion of s l ides in a 2% hydrogen peroxide solution in  
double dist i l led H20 for five minutes at room temperature. After another wash in  0 .0  I M 
PBS ,  the cel l s  were equi l ibrated in I X  labeling buffer while the label ing mixture was 
prepared. 
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The labeling mixture consisted of I II I of Tdt dNTP mix, I II I of SOX Co2+, and I II I of Tdt 
enzyme for every 50111 of I X label ing mix.  This label ing mixture was added in 1 5111 
al iquots to each spot and the sl ides were placed in a humidified chamber for a I hour 
i ncubation at 37°C. After the incubation period, the sl ides were immersed in  I X  Stop 
Buffer for 5 minutes at room temperature. The cells were washed in O.O I M  PBS and then 
treated with streptavidin-horseradish peroxidase for 10 minutes at room temperature. 
After another wash in O.O I M  PBS ,  the sl ides were immersed in a DAB solution of 0.25ml 
of DAB stock solution and 50111 of 30% H202 in 50ml of 0.0 I M PBS for 10 minutes at 
room temperature. The slides were careful ly  rinsed in  water and dehydrated w ith 
sequential i mmersion in  50% ethanol ,  70% ethanol, 95% ethanol , 1 00% ethanol , and 
finally Xylene. The sl ides were then covers l ipped using Protex mounting medium. 
2 .6 Immunocytochemistry 
For the i mmunocytochemistry, an antibody against the glucocorticoid receptor was obtained 
from Santa Cruz B iotechnology. The affin ity purified polyclonal rabbit antibody was directed 
against the amino acids 750-769 at the carboxy terminus of an alpha human glucocorticoid 
receptor and arrived in  an initial concentration of 200llg/ml .  The GR (P-20) was then di luted 
to a working concentration of 4llg/ml in O.O I M  PBS/O. l % bovine serum albumin (BSA).  
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The Vectastain ABC anti-rabbit kit by Vector (Burl ingame, CA) was used to reveal the 
binding of the antibody to the receptors . Vectastain reagents (blocking serum, biotinylated 
antibody, and ABC reagent) were prepared as stock solutions according to the protocol 
outlined by Vector. The cells used in immunocytochemistry were fixed as described above. 
The sl ides were immersed in O.O I M  PBS at room temperature for 5 minutes to hydrate the 
cel l s .  The s l ides were then removed from the PBS and excess fluid was removed from the 
s l ides whi le not allowing the cel l s  to dessicate. Between each step, the sl ides were washed 
with 1 0ml  of 0.0 I M PBS using a syringe, immersed in  PBS, and dried in the manner just 
described. Reagents were applied using a I ml syringe to form a bubble of fluid on the spotted 
cel l s  unless otherwise noted. The cells were permeabi l ized in Cytopore (20lll/spot applied by 
micropipet) for 30 minutes at room temperature. This incubation and all subsequent 
incubations were carried out in an airtight humidified chamber. 
Next, a blocking solution of 0. 1 % immunohistochemical-grade BSA in 0.0 1 M PBS (pH 7 .4) 
was appl ied to each spot for 20 minutes at room temperature to prevent non-specific binding 
of immunoreagents. This blocking solution is also used as the biotinylated antibody veh icle 
(BA V) .  The glucocorticoid receptor antibody was then added to each spot for a 3 hour 
incubation at room temperature. An internal control of PBSfBSA was applied to one spot in 
each experiment as a negative control to show that the secondary antibody bound specifical ly 
to the aGR. After this incubation, the secondary antibody was added to each spot. This 
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Vectastain biotinylated antibody was a 1 2 .S% di lution in BAY of the standard working stock 
and was appl ied for 30 minutes at room temperature. The sl ides were treated with a 20% 
di lution of the standard worki ng stock of Vectastain ABC reagent in 0.0 I M PBS (pH 7 A) for 
30 minutes at room temperature. 
The sl ides were washed in PBS and then immersed in a DAB solution of 1 2.Smg DAB in 
SOml of O.OSM Tris HCL (pH 7 .6) with SOIlI of 3% hydrogen perox ide. After this 1 0  minute 
incubation at room temperature, the slides were dehydrated by sequential exposure to ddH20, 
SO% ethanol ,  70% ethanol, 9S% ethanol, 1 00% ethanol, and then Xylene. Fol lowing the 
Xylene exposure, the slides were coverslipped with Protex mounting medium. 
2 .7  Determining Polyc1onal Rabbit Antibody Specificity by Antibody Absorption 
The specificity of the GR polyc1onal rabbit antibody (aGR) was determined by incubation of 
the antibody with a ten fold concentration of its complement peptide which absorbs the 
antibody. For this antibody absorption, 41lg of the GR peptide in 1 0111 of O.! M PBS/O. ! %BSA 
was added to 1 00111 of aGR (OAllg/ l OOml) .  The negative control consisted of 1 0111 of 
PBS/O.02%BSA added to 1 00111 of aGR (OAllg/ l OOm!) .  These samples were incubated 
overnight at 4°C. These samples were then used as primary antibodies in an ICC on Nb2 cells. 
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The specificity of the antibody was val idated if the absorption e l iminated staining (Witorsch, 
1 980). 
2.8 Photography and Staining Quantification 
Photomicrographs were taken using a Nikon Ecl ipse E800 Microscope fitted with a 
DKC-5000 Sony Digital PhotoCamera. The images captured by the digital camera were 
i mported into Adobe Photos hop as a TIFF Graphics file .  To obtain cell samplings 
representative of the entire field, photomicrographs were taken of four fields at positions 
analogous to 3, 6, 9, and 1 2  o'clock in the etched circle.  If a larger sample size was needed 
( i .e.  number of cells), additional photomicrographs were taken at 1 , 4, 7 ,  and I I  o'clock on the 
etched circle .  Scion Image, an image analysis program (Scion Corp, Frederick, Maryland) was 
then used to quantify stained versus unstained cells in the photomicrographs. The 
photomicrograph was opened as a black and white image and the total cells were counted by 
adjusting the threshold of the image so that only the outlines of the cells were visible. The 
"Analyze Particles" option was then used to count the visible cel l  outlines. To count stained 
cel ls, the threshold of the black and white image was lowered so that only the stained 
inclusions of the cells were visible rather than the cell outlines. This el iminates the unstained 
cells from the visible field which was again counted using the "analyze particles" function. 
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2.9 Statistics 
Linear regression analysis was performed on the clonal and wild type data for comparisons of 
cytolytic data, TUNEL data, and GR staining data (all as percent cells). The correlation 
coefficients generated by a l inear regression are indicative of the relationship between two 
populations (Daniel, 1 999). Also, mean values of the four treatments of the cytolytic assay for 
clonal and wild type data were generated and the treatments were compared by analysis of 
variance (ANOY A) with a post-hoc test (Duncan's multiple range tests) .  Al l  statistical 
analysis was performed using the computer software S igma Stat (Yersion 2 .0). The minimum 
level of significance used was Ps;0.05 . 
Chapter 3 
RESULTS 
3 . 1 Generation of Clones 
A total of 28 Nb2 clones were obtained from 4 different l imiting di lutions (series 3-6) as 
shown in Table I. These clones were examined for GR presence and their response to 
Dex ± PRL via TUNEL and Trypan Blue exclusion. A total of eight wi ld type Nb2 cell 
samples were also examined with each l imiting di lution. 
3.2 Immunocytochemistry and Antibody Absorption for GR 
Immunocytochemical testing revealed specific immunostaining of GR in al l  wild type 
Nb2 cel l s  and clones generated by l imiting di lution and this specificity was establ ished by 
immunoabsorption. Figure I (A) shows heterogeneous staining of a wi ld type Nb2 cells 
for GR typical of both WT and clones of Nb2 cells. As reported previously (Guanzon, 
M . S .  thesis, 1 998)  the staining appears primari ly in the periphery of the cel ls and is 
typical of Nb2 log phase cells. Figure I (B) shows immunospecificity where 
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immunostaining is el iminated when the antibody was incubated with a l OX concentration 
of its antigen for 24 hours prior to use in the ICC. 
3 . 3  Effect of Dex ± PRL on WT and Clone Nb2 cells 
The responsiveness of Nb2 cells (WT and clones) to hormones was evaluated in  using 
two endpoints - percent dead cells as determined by Trypan B lue exclusion and TUNEL 
label ing.  Figure 2 provides an example of TUNEL labeling of Wild Type Nb2 cells 
fol lowing exposure to Dex ± PRL. The cells in  Figure 2 (A) were treated with DMSO 
and exhibit l i ttle TUNEL labeling. The Dex treated cells in Figure 2 (B)  show a marked 
increase of TUNEL labeling which decreases in the Dex treated cells co-incubated with 
PRL (Figure 2 (C)) .  Figure 2 (D) displays the PRL treated cells which are virtual ly 
unlabeled. These data are consistent with previous observations (Guanzon, M.S. thesis, 
1 998)  and simi lar trends in TUNEL labeling were observed for the clones when subjected 
to the cytolytic assay. 
The quantitative responses of individual c lones and wild types to Dex ± PRL are shown 
in Table I .  In both WT and clones, variabil ity was observed in  the cytolytic and TUNEL 
response to Dex . For example the Dex-induced WT percent increase in dead cells above 
DMSO control ranged from 45% to 78% for WT cells. The TUNEL labeling showed a 
change from 40% to 68% above DMSO control for the WT cells. The clones showed a 
change in percent dead ranging from 37-95% and a change of 3 1 -9 1  % for the TUNEL 
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labeling. In addition the WT cells showed a variation in GR staining from 48-83% and 
the c lone GR staining ranged from 52-87%. The PRL protective effect was seen in every 
WT and c lone sample treated with Dex. In 4 of the 7 WTs, PRL brought the percent dead 
back to the baseline values, while the other 3 WTs exhibited a partial PRL inhibitory 
effect. In the clones there also was a variabi l ity in the magnitude of the PRL inhibitory 
effect on Dex induced apoptosis. Fourteen out of twenty-three c lones showed a complete 
inhibition of cytolysis while the remaining nine clones showed partial inhibition by PRL. 
Simi larly eleven of twenty-two clones showed inhibition of apoptosis as measured by 
TUNEL labeling and eleven showed partial inhibition. In the absence of DEX, percent 
dead or TUNEL labeling after PRL was at the baseline DMSO level or less in al l  c lones 
and WTs. 
3 .4 Correlations Between Trypan Blue Staining, TUNEL Label ing, and GR Staining 
Linear regressions were conducted between individual values of clones and wild samples 
for GR, percent dead, and percent TUNEL labeled cells. As shown in Figure 3 a 
statistical ly significant (P<O.OOO I )  correlation was observed between GR staining and 
percent dead after Dex treatment. Figure 4 shows that a statistical ly significant 
correlation existed between percentage of cells stained for GR and increase in percentage 
of cel ls dead from DMSO after Dex treatment. Figures 5 and 6 simil arly compare GR 
staining with TUNEL counts. Unlike Trypan B lue counts, a statistical ly significant 
correlation could not be demonstrated between individual TUNEL values and GR values. 
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In Figures 7 and 8, the relationship between TUNEL label ing and percent dead counts 
was examined when cells were treated with Dex .  Neither comparison, percent TUNEL 
labeled after Dex versus percent dead after Dex (Figure 7) nor increase in TUNEL 
labeling after Dex treatment versus increase in percent dead after Dex (Figure 8) showed 
significant correlations. In Figure 9 TUNEL and percent dead values were correlated for 
all four treatments of the cytolytic assay. Here TUNEL and cytolysis are highly 
correlated (P<O.OOO I ) . 
3 .5  Comparison of Means of Clone and WT Data for TUNEL, Trypan B lue, and GR 
Figure 1 0  compares the mean values of TUNEL labeling and percent dead cells for the 
four treatments of the cytolytic assay on the Nb2 Wild Type cells. The mean for GR 
staining counts is also included for comparison with the Dex treatment resu lts. A 
response to Dex and its inhibition by co-incubation with PRL is c learly seen for both 
endpoints. Furthermore, cytolytic and TUNEL mean values are very c lose to one another 
for each treatment. In addition, the percent GR staining corresponds quite closely to 
percent dead and percent TUNEL labeled values for the Dex treatment. Figure I I  
simi larly examines the mean values of TUNEL label ing and percent dead cells for the 
c lones . The clones again display a definite response to Dex which is inhibited by co­
incubation with PRL as seen by TUNEL labeling and percent dead cells. The TUNEL 
mean values are very close to the percent dead mean values for each treatment and the 
percent GR staining is very close to the Dex mean values for both endpoints. Also the 
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mean values of the clones are very similar to the mean values of the WT cells for each of 
the treatments (Figure 1 0  compared Figure I I ) . 
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Figure 1 .  (A) shows WT Nb2 cel ls stained with an antibody to GR at a concentration of 
4IJ.g/mi .  (B) demonstrates the disappearance of this staining when the aGR is absorbed 
out by incubation with the antigen peptide concentration at 40IJ.g/ml . (20X obj ective 
magni fication). 
A. 
,l  
B. 
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Figure 2. TUNEL labeling of Wild Type Nb2 cells subjected to the cytolytic assay. (A) 
shows the control cells incubated with DMSO (0.25%). Very few cells were labeled for 
apoptotic activity. The cel ls in Figure 2 (B) reveal the effect of Dex treatment ( I OOnM) 
as an increase in TUNEL labeling is readily apparent. Figure 2 (C) demonstrates the 
inhibitory effect of PRL ( I  ng/ml) co-incubation with Dex treated ( 1  OOnM) cells. The 
frequency of observing apoptotic cells decreases from the Dex treated cells. The cells in  
Figure 2 (D)  were treated wi th  PRL ( 1  ng/ml) alone and exhibit no TUNEL labeling.  (20X 
objecti ve magnification) 
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A .  DMSO 
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c. Dex ( I OOnM) + PRL ( I nglmJ) 
D. PRL ( l nglmJ) 
Table 1 .  Effect of Dex +/- PRL on Trypan Blue Exclusion and TUNEL Staining of WT and Clone Nb2 Cells 
TREATMENT 
Wild Type DMSO Dex ( I OOnM) Dex ( I  OOnM ) + PRL ( I  ng/ml) Change % of cells 
Sample PRL ( I  ng/ml) after Dex treatment" GR (+)d 
Dead' TUNELb Dead TUNEL Dead TUNEL Dead TUNEL Dead TUNEL 
3WT 1 2 .5 1 0.0 7 1 .4 78.2 58 .9 68.3 7 1 .8 
4WTI 8 .6 84.2 7.0 5 . 1  75.6 64.4 
4WTI 1 0.9 77.7 1 5 .6 3.9 66.8 6 1 .3 
4WT3 1 3 .2 1 3 . I 74.3 68. 1 1 6.3  26.7 4.6 I I  .6 6 1 .  I 55. 1 48. 1 
5WTI 1 4.5 92.7 35.9 3 . 8  78.2 82.6 
5WT2 1 4.2  58 .6  I I .  I 8 . 8  44.5 
5WT3 6.8 5 .2  76.6 72.4 30.2 27.6 8.0 3 .4 69 . 8  67.2 79.7 
6WT 1 2.8 7.2 84.2 47.2 20.5 9.9 4.7 1 .6 7 1 .5 40.0 78.0 
Clone # 
3-4 1 8 . I 22.9 88.7 87.9 70.6 65.0 7 1 .2 
3-5 1 6.8 1 2 .7 66.0 46.3 49.2 33.7 57.4 
3 - 1 1 9.4 1 1 .9 79.8 73 .0 70.4 6 1 .0 73 .0 
3- 1 5  9 .2  1 1 .9 56.3 43. 1 47. 1 3 1 .3 66.2 
3-20 1 3 .  I 1 8 .3  6 1 .5 66.2 48.4 47.9 66.4 
4-2 7 .7  7 .4 84.5 5 1 .7 5.9 1 7 .8 2.6 4.3 76.8 44.3 83.4 
4-5 9.4 1 5 . 8  8 1 .4 74.7 4.6 1 5 .4 8 .0 4.4 72.0 58.8 83.5 
4-7 4.4 9.7 9 1 .6 75 .0 33.9 2 1 .6 4. 1 7.6 87.2 65.4 72.3 
4- 1 4  1 4 .6 25.8 69.5 79.4 20.5 25.6 6.8 6.9 54.9 53.6 72.9 
4- 1 6  1 0.5 1 6.0 79. 1  47.5 1 7 .7  1 8 .9 7.3 8 .6 68.7 3 1 .5 67.7 
4-2 1 1 3 .7  1 6.2  78.5  76. 1 24.7 I I  .7 7.2 6.2 64.8 60.0 54.8 
4-22 8 .2 1 3 .8 94. 1 77.2 39.2 38 .5  1 5 .7 8.0 85.9 63.3 84.9 
4-23 1 5 .3  1 6.0 90.5 59.6 1 6.0 1 0.6 20.9 7.4 75.3 43.6 87.2 
'percent dead cel ls as determined by Trypan Blue exclusion 
bpercent cells stained for apoptosis by TUNEL labeleing 
'increase in % above DMSO (control) 
dcells stained for GR using ICC VJ VJ 
Table 1 Continued 
TREATMENT 
Clone DMSO Dex ( I OOnM) Dex ( l OOnM) + PRL ( I  ng/ml) 
# PRL ( I ng/ml) 
Dead" TUNELb Dead TUNEL Dead TUNEL Dead TUNEL 
5-4 5.4 1 00.0 30. 1 4.4 
5-8 1 0.5 7.5 66.7 73 .  I 1 3 .4 1 7 .5 4.5 3 .5 
5- 1 0  9.0 4.6 62.6 69.6 22. 1 1 3 .3 1 . 1  3 . 3  
5- I I  1 5 .0 1 1 .0 52.4 8 1 .6 1 4.9 1 8 .6  4. 1 1 2.0 
5- 1 3  6.3 5.3 53.4 50.2 4.0 3 .3 2 .2  0.7 
5- 1 7  1 6.7 1 2.5 69. 1  73 . 1 1 2.0 1 4 .4 2 .8  8 .9 
5-23 1 5 .2 1 8 .3  74.6 72.  I 1 3 .2 29.3 3 .9  7 .8  
6-2 1 1 .6 82.9 47.0 7 .6  
6-3 1 6.6 1 2 .5 67.7 6 1 .3 6 .2  5 .  I 3 .5  2 . 1 
6-7 1 9 .5 1 5 .6 92.3 88 .0 23 .2  38.7 1 0.3  3 .8  
6- 1 1  1 3 .3  9.9 67. 1 84.3 1 7 .2 2 1 .5 1 0.8 6 .5 
6- 1 4  1 2 .0 1 4 .6 98.4 75.6 53.3 49.9 1 2 .3  
6- 1 6  1 2 .2  4 . 1  95.9 94.7  
6-20 1 2.7 8 . 1 89.3 74.6 35.6 26.5 8.9 4.7 
6-22 1 6.2  I J .7 73.4 87.5 8.2 22.6 5.0 2.3 
·percent dead cells as determined by Trypan Blue exclusion 
bpercent cells stained for apoptosis by TUNEL labeleing 
'increase in % above DMSO (control) 
dcells stained for GR using ICC 
Change 
after Dex treatment" 
Dead TUNEL 
94.6 
56.2 65.6 
53.6 65.0 
37.4 70.6 
47. 1  44.9 
52.4 60.6 
59.4 53.9 
7 1 .3 
5 I .  I 48.8 
72.8 72.4 
53.8 74.5 
86.4 6 1 .0 
83.6 90.6 
76.5 66.5 
57. 1 75.8 
% of cells 
GR (+)d 
87.2 
57.5 
65.2 
59.2 
59.3 
52.5 
58.6 
8 1 .5 
75.5 
72.0 
65.2 
79.5 
73 . 1  
83.0 
76.7 
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Fig. 5 .  Percentage of cells stained for GR versus percentage of cells 
labeled by TUNEL after Dex treatment. Correlation does not show a 
statistically significant relationship. 
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Correlation does not show a statistically significant relationship. 
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This is not a statistically significant relationship. 
39 
1 00 
>-. C<l CI) CI) 
<t:: 
.....l 
u.J 
Z 
:;:J 
E-< 
>-. 
.D 
"0 
cU 
c: 
.§ 
CIl 
CI) 
"0 U 
C 
cU 
u ..... 
cU 
0.... 
.::: 
cU 
on 
c: C<l 
.c: U 
40 
1 00 
90 • 
80 
• • 
70 • • • • • • • • • 
60 • 
50 
• • 
• • • 
40 • 
• 
• • R=0.239 30 R2=0.057 
P=0.2041 
20 
30 40 50 60 70 80 90 
Change in Percent Cell s  Dead after Dex Treatment 
Fig .  8. Change from DMSO in percent dead cells after Dex 
treatment versus their the change from DMSO in percentage of cells 
stained by TUNEL. This is not a statistically s ignigicant relationship. 
;>., � V'l 
V'l 
« 
.....J 
t..Ll 
Z 
:::J 
E-
;>., 
.D 
"0 
Q) 
c 
' c;j  
r/J 
� 
"0 U 
C 
Q) 
u ..... 
Q) 
0.... 
4 1  
1 00 
• 
• • •  • 
80 • ... • ... . .. -• 
• 
60 • 
• 
• • •  
40 • • 
• 
20 • 
R=O,943 
0 R2=O,889 
P<O,OO01 
0 20 40 60 80 1 00 1 20 
Percent Cells  Dead 
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(DMSO, Dex, Dex+PRL, and PRL) versus the corresponding percentage 
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( 1  ng/ml)  alone. The Dex means differ in a statistically significant 
(P<0.05 ) increase in TUNEL labeling or % dead cells but the other 
treatments are not significantly different from the control .  
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Fig. 1 1 . Comparison of means (+/- SE) for TUNEL labeling, % dead, 
and % GR staining for all c lones. The four treatments are DMSO 
(0.25%), Dex ( l OOnM), Dex ( l OOnM) plus PRL ( l ng/ml), and PRL 
( 1  ng/ml) alone. The Dex means differ in a statistically significant 
(P<0.05) increase in TUNEL labeling or % dead cells but the other 
treatments are not significantly different from the control .  The 
Dex+PRL treatment does differ from the PRL alone treatment. 
Chapter 4 
DISCUSSION 
The objective of this study had been to isolate clones of the Nb2 lymphoma cell l i ne that 
were glucocorticoid receptor enriched and deprived of these receptors and to use these 
clones to determine whether GR is predictive of cytolysis as measured by Trypan Blue 
exclusion and apoptosis as measured by the TUNEL assay. In actuality no completely 
enriched GR clones were obtained nor were there two distinct groups of primarily GR 
enriched and primarily GR reduced c lones. A statistical ly  significant rel ationship was 
found between the percentage of cells stained for GR and cytolysis after Dex treatment as 
measured by Trypan Blue exclusion (Fig. 3 and 4). A statistically significant correlation 
between TUNEL l abeling after Dex treatment and GR staining was not found (Fig .  5 and 
6). Furthermore, the correlation between TUNEL labeling and cytolysis after Dex 
treatment was not found to be statistical ly significant (Fig. 7 and 8). However, when the 
TUNEL and cytolysis data for all treatments of cells (DMSO, Dex,  Dex + PRL, and PRL) 
were regressed, a very high, statistically significant relationship was found (Fig. 9) .  
When analyzing the mean values of the clones and wild types for each treatment, the 
TUNEL and percent dead mean values were very close to one another (Fig. 1 0  and I I ) . 
In addition, the Dex effect could clearly be seen and the mean percent GR staining values 
were very simi lar to the Dex response values as measured by Trypan Blue or TUNEL. 
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The wi ld type cells and clones also exhibited mean values for all treatments which were 
very close to one another (Fig. 1 0  and I I ) .  
The l imiting di lution method in  this particular study was modified and practiced twice 
before implementation in order to refine the method for our purposes. We used the 
l imit ing di lution method in preference to the transfection methods because it  would 
appear to be a much more natural process of obtaining cel l s  with specific characteristics, 
such as GR. Transfection also does not ensure the presence of other signals associated 
with GR that may be necessary for whatever processes GR mediates. Presumably this 
cascade of signals would be found in GR possessing cells .  One of the above-mentioned 
refinements to the method we employed was to dilute the cel l s  to a concentration of 0.5 
cel ls/ml before plating at a final volume of I ml .  At this dilution of cel ls ,  one cell is l ikely 
to be plated in every other well which minimizes the possibi l ity of heterogeneity. The 
clones were also tested at the earliest possible time point in order to l imit  any cel lu lar 
changes that may occur due to prolonged growth in the media. The clones were also not 
"split" at any time in order to keep the entire c lone population intact as the cells 
pro l i  ferated. 
The results of the immunoabsorption study verified the specificity of the GR ant ibody 
used in the ICC experiments (Witorsch, 1 980). This el iminated the possibi l ity of non­
specific staining and thus the ICC staining should  be a valid visualization of GR presence 
in the various clone Nb2 cell  l ines . We expected two populations of cel ls - GR posit ive 
and GR negative - but obtained neither. This may be a reflection of the natural way in 
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which neoplastic cells behave. Neoplastic cells in culture differ from normal cel ls in a 
variety of ways. Neoplastic cel ls do not exhibit contact inhib ition nor do they have a 
rel iance on cell adhesion. Neoplastic cells also are known to exist at an intermediate 
level of differentiation. Differentiated cells do not usually prol iferate so a neoplastic cell 
is usual ly at an earl ier stage of differentiation. Neoplastic cel ls are also thought to 
dedifferentiate. These cells do not actually revert to a more primitive, undifferentiated 
precursor of that cell l ine but rather lose normal characteristics and function with tumor 
progression. Dedifferentiation can also be referred to anaplasia and may be the reason 
why we were unable to obtain GR enriched clones. Even though the cells were harvested 
at the earliest timepoint possible, they may have sti l l  undergone prol iferation during 
which this dedifferentiation could occur (Braun, 1 974; Franks, 1 986). 
The absence of GR positvie cells may have been due to the fact that the WTs were GR 
enriched to begin with. Guanzon showed lower GR staining and GC response than what 
we found. The Nb2 cel ls used in  this work were from a l ine of cells provided by Dr. 
Peter Gout at the Cancer Control Agency of British Columbia and were representative of 
the original wild type Nb2 cell l ine.  The Nb2 cel l s  used in our previous ICC studies 
(Guanzon, M . S .  thesis, 1 998) were originally provided by Dr. Gout but had been at 
another laboratory at our institution prior to being made available to us. In contrast to the 
cells used in this study, the cel l s  in Guanzon's study had undergone many more passages 
before being used in experiments. This may have been the reason why those cells showed 
approximately a 40%-50% response to Dex while the wild type Nb2 cells in the present 
study showed on average a 70%-80% response to Dex .  In addition 70% of the cells in  
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our study stained positive for GR while Guanzon showed only about 40% staining for GR 
in those Nb2 cel ls .  The wild type Nb2 cells were thus already an enriched GR cel l  l ine 
and that may have prevented the isolation of an even higher GR enriched clone. This 
however, does not explain why a GR devoid clone was not isolated. An alternate method 
for isolating a GR negative clone may be necessary. One possible method would be to 
incubate the wild type Nb2 cel ls in a cytolytic concentration ( l OOnM) of Dexamethasone. 
This would presumably induce apoptosis in the cel ls with glucocorticoid receptors but 
not in GR negative cel ls .  The GC resistant cells would  then prol iferate establishing a GR 
negative clone of Nb2 cel ls .  However evidence does exist for the possibility of GC 
resistance lymphocytes with ful ly functional glucocorticoid receptors (Witorsch et a I . ,  
1 993 ;  Oldenburg et aI . ,  1 997). Alternatively, starting with Nb2 cel ls  with lower 
percentage of GR positive cells may lead to better isolation of GR enriched and deprived 
clones. Preliminary studies in our lab show that the GC response of Nb2 cel ls decreases 
with time. 
The correlations performed on the TUNEL labeling, cytolysis counting, and GR staining 
data presented some meaningfu l  insights. The cytolysis induced by Dex treatment, 
presumably via apoptosis, showed a statistical ly significant relationship with the 
percentage of cells stained for GR. This relationship suggests that the apoptotic effect of 
glucocorticoid on the Nb2 cell can be predicted by the proportion of cel ls  stained for the 
glucocorticoid receptor in the population. The TUNEL l abeling did not show this same 
expected correlation nor did the TUNEL label ing correlate with the percent cel l s  dead 
after Dex treatment. The high statistical ly significant correlation between TUNEL 
l abeling and cytolysis for data from all 4 treatments of the cytolytic assay shows that these 
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two endpoints for apoptosis do in fact describe the same phenomenon over a broad range 
of values. In this combined correlation, the TUNEL labeling values and percent dead 
values ranged from nearly 0% to well over 90% which easily separated high, 
intermediate, and low response values from one another. If the l imiting dilution had 
produced clones in the expected highly enriched and devoid subsets, the Dex response 
data may have given this wide distribution of values needed for correlating TUNEL 
label ing and cytolysis. 
After having conducted statistical analysis on the data generated from the 28 clones and 8 
individual experiments involving wild type cells, the l imitations of the methodology were 
more apparent. Perhaps the most apparent l imitation of the methodology was the 
imprecision of the immunocytochemical approach to the data. For the Trypan B lue 
exclusion values obtained in this study, each c lone sample was counted in tripl icate. This 
meant that three different aliquots of cel l s  were taken from each treatment wel l  and 
examined via hemocytometer counts of Trypan Blue exclusion. Previous work in our 
laboratory had shown that a single Trypan Blue count of a cell population can produce as 
much as a 40% variation from any other count taken of that same sample. Triplicate 
counts ensured precision and accuracy of the cell while being t ime and cost effective. 
When twelve counts were taken from the same sample, any three counts of that twelve 
would give a mean that was within 1 0% of the mean for the twelve counts. The 
quantitation of the TUNEL and GR staining may not have had this desired precision and 
accuracy. For the TUNEL and ICC assays, a 1 0111 sample of fixed cel l s  was taken from 
each treatment of the cytolytic assay and spotted onto a s l ide. The cel l s  on the sl ides were 
then subjected to ICC or TUNEL labeling and visualized using a microscope. The 
49 
quantitation of staining involved taking 4-8 pictures of each treatment for each clone. 
The pictures for a given treatment were taken at regular intervals in  the field to give a 
representative view of the entire field of cel ls as described in the Methods section. The 
minimum number of cells counted for any treatment was about 60-62 cells with an 
average of 205-208 cells counted for all clones and wild types for all treatments. The 
mul tiple photographs and number of cells counted were steps taken to el iminate variation 
in the sample which could skew the data. However, the methodology did not account for 
variabi l ity which could occur when only one aliquot is examined from a given fixed cell 
population. In order to better emulate the hemacytometer counting, a minimum of three 
aliquots of fixed cells should have been spotted for every treatment of every clone. This 
inherent methodological variabil ity l ikely prevented a more accurate correlation of the 
data. Even the correlation between the Dex response (as measured by cytolysis) and the 
GR staining could have been higher if  the data for the GR had been measured in a manner 
c loser to the hemacytometer counting. This would have held true for the GR versus 
TUNEL label ing correlations as wel l .  The TUNEL labeling versus percent dead cells for 
all treatments showed a very high correlation, but the wide range of values probably 
minimized the effect of the variabil ity in the TUNEL samples. With more accurate 
counting of TUNEL labeling, the Dex-induced response may have correlated with the 
percent dead cells by itself ( i .e .  without pooling all treatments). This possible l imitation 
in the methodology was not anticipated but could be overcome in future experiments. 
The mean values of the clones and wild types for the four treatments also revealed some 
interesting relationships. The mean values for TUNEL label ing and cytolysis were very 
s imi lar to one another for both the clones and the wild type cells .  This is another 
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indication that these two end points are essentially detecting the same phenomenon 
(apoptosis) .  By using the mean values of a relatively large population for each treatment, 
the possible variabi l ity of the individual clones made less of an impact on the results. In 
addition the mean values of GR staining were similar to the mean values of cytolysis and 
TUNEL labeling after Dex treatment. This again demonstrates the relationship between 
GR and GC-induced apoptosis  which may not have been as clear with the correlations of 
the individual clone samples. The clone and wild type mean values were very close to 
one another for al l four treatments as well as for the GR and maybe be a further indication 
that the individual clones eventual ly dedifferentiate to exhibit the same phenotype as the 
wi ld type cel ls .  
The Dex response of the wild type and clone Nb2 cells, as well as the inhibition of this 
response w ith PRL co-incubation, concurs with previous findings in our laboratory 
(Fletcher-Chiappin i  et a ! . ,  1 993;  Guanzon, M.S .  thesis, 1 998) .  The data also show that 
cel l s  that have GR wi l l  be induced into apoptosis by Dex treatment. Although this might 
be expected, there i s  evidence of lymphocyte cell l ines which have functional GR yet 
cannot be induced into apoptosis by Gc. The SFJCD I cell l ine, a clone of the Nb2 cell 
l ine which prol iferates independently of exogenous PRL, is one such example. This cell 
l ine demonstrated anti prol iferative effects when incubated with Dex demonstrating 
functional GR action, but the cel ls did not undergo apoptosis when treated with Dex 
alone (Witorsch et a ! . ,  1 993) .  Work with human leukemia and lymphomas has also 
shown that "the lack of response . . .  to steroid therapy cannot be attributed to the absence of 
glucocorticoid binding or presence of altered receptors. "  (Stevens et a! . ,  1 985) More 
recently Oldenburg et a! . ( 1 997) have demonstrated rat thymocytes with functional 
5 1  
glucocorticoid receptors which are glucocorticoid resistant in Vivo but not in Vitro. With 
these studies in mind, the present work is significant in showing that GR presence in the 
Nb2 cell line is predictive of the apoptotic response. 
The correlation between cytolysis and GR also reveals another interesting characteristic 
of apoptotic cel ls .  If Dex had induced necrotic death in the Nb2 cells, the necrosis would 
have caused the release of toxins from dead cel ls  which would in turn cause further cel l  
death. In effect the stimulation of one GR would have caused the death of cel ls  devoid of 
GR in a necrotic fashion. The experiments in this study actually show a direct 
rel ationship between cytolysis and the presence of GR which is more indicative of 
apoptosis where individual cells are selectively chosen to undergo death processes. 
Although the desired GR enriched and deprived Nb2 cell l ines were not obtained, the 
findings are useful to future work in generating and examining Nb2 clones expressing 
specific proteins or signals .  Perhaps most importantly, the method of 
i mmunocytochemical quantitation would have to be refined further to provide for more 
accurate estimation of cellular markers. This study only examined apoptosis in the Nb2 
cel l  as related to the GR, but other studies in our laboratory are examining other 
intracel lular signals involved in apoptosis .  Perhaps the combination of the infonnation 
gained in this study with the infonnation on signals such as ST AT5b, IlCBa, and NFlCB 
wi l l  provide a better overall understanding of apoptosis and the intracel lul ar signals that 
mediate those processes in Nb2 cel ls .  
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